Digital Health August 29, 2024
Tammy Lovell

  • The use of autonomous AI could speed up diagnosis and reduce wait times for skin cancer pathways, according to a report commissioned by NHS England
  • The report evaluates the adoption of AI as a medical device (AIaMD) in suspected skin cancer pathways and assesses its safety and effectiveness
  • Researchers examined real-world data from over 33,000 lesions assessed by DERM, an AIaMD developed by Skin Analytics

The use of autonomous AI could improve effectiveness and reducing wait times for skin cancer pathways, according to a report commissioned by NHS England.

AI as a medical device (AIaMD) is employed under human supervision in skin cancer pathways and can be used autonomously in the NHS if certified under classes UKCA IIa...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Provider, Survey / Study, Technology, Trends
Related Articles:
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article